Technical Specifications
| Drug Composition | Lenvatinib 4 Mg Capsule |
|---|---|
| Variant / Strength | 4 mg |
| Dosage Form / Type | Capsules |
| Product Benefits | Thyroid cancer |
| Packaging Type | Strip |
| Delivery Time | 7 - 15 Days, as per delivery location. |
| Country of Origin | Made in India |
Product Overview & Description
Lenvatinib Capsule is an orally administered receptor tyrosine kinase inhibitor prescribed for the treatment of thyroid cancer.\n\nThis capsule can be consumed with or without food, but it is recommended to take it at the same time each day to maximize its benefits. The doctor determines the required dosage and frequency based on the patient's specific condition, which may vary over time. It is essential for the patient to adhere precisely to the doctor's instructions, as incorrect administration or excessive intake can lead to severe side effects. While it might take several weeks or months for the patient to observe the benefits, discontinuation should only occur under the doctor's explicit instruction.
Submit Quotation Request
Verified Customer Reviews (0)